Pityriasis Rubra Pilaris
📧 Sign up to get email alerts when something new happens for Pityriasis Rubra Pilaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris [Phase 2]
Phase 2 trial results of deucravacitinib (BMS-986165) for pityriasis rubra pilaris have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP [Phase 4]
Phase 4 clinical trial assessing Bimzelx (bimekizumab) for adult-onset pityriasis rubra pilaris is listed under Mayo Clinic sponsorship. The…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris [Phase 2]
Phase 2 clinical trial update for Deucravacitinib in pityriasis rubra pilaris. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) [Phase 2]
A Phase 2 trial evaluating guselkumab for pityriasis rubra pilaris has completed and results were posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) [Phase 2]
Phase 2 trial update for ixekizumab in pityriasis rubra pilaris has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris [Phase 4]
Phase 4 pilot trial evaluating alefacept for pityriasis rubra pilaris was terminated; results were posted in 2018.